|
MX373121B
(es)
|
2010-05-14 |
2020-04-30 |
Dana Farber Cancer Inst Inc |
Composiciones y metodos para el tratamiento de leucemia.
|
|
MX384074B
(es)
|
2010-05-14 |
2025-03-12 |
Dana Farber Cancer Inst Inc |
Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
|
|
US9301962B2
(en)
|
2010-05-14 |
2016-04-05 |
Baylor College Of Medicine |
Male contraceptive compositions and methods of use
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
EP2705039B1
(en)
|
2011-05-04 |
2017-07-26 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
US9328117B2
(en)
|
2011-06-17 |
2016-05-03 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013033270A2
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
|
|
WO2013033269A1
(en)
*
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
|
|
DE102011082013A1
(de)
|
2011-09-01 |
2013-03-07 |
Bayer Pharma AG |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
TWI602820B
(zh)
*
|
2012-06-06 |
2017-10-21 |
星宿藥物公司 |
溴域抑制劑及其用途
|
|
US9624244B2
(en)
|
2012-06-06 |
2017-04-18 |
Constellation Pharmaceuticals, Inc. |
Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
WO2013185284A1
(en)
|
2012-06-12 |
2013-12-19 |
Abbott Laboratories |
Pyridinone and pyridazinone derivatives
|
|
EP2861255B1
(en)
|
2012-06-19 |
2019-10-09 |
The Broad Institute, Inc. |
Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy
|
|
PE20150729A1
(es)
|
2012-08-16 |
2015-06-14 |
Bayer Pharma AG |
2,3-benzodiazepines
|
|
HK1208448A1
(en)
|
2012-09-28 |
2016-03-04 |
Bayer Pharma Aktiengesellschaft |
Bet protein-inhibiting 5-aryl triazole azepines
|
|
JP6401773B2
(ja)
|
2013-03-11 |
2018-10-10 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤およびこれを用いる治療方法
|
|
CN105026403B
(zh)
*
|
2013-03-12 |
2018-05-18 |
艾伯维公司 |
四环布罗莫结构域抑制剂
|
|
US9714946B2
(en)
|
2013-03-14 |
2017-07-25 |
Dana-Farber Cancer Institute, Inc. |
Bromodomain binding reagents and uses thereof
|
|
WO2014159837A1
(en)
*
|
2013-03-14 |
2014-10-02 |
Convergene Llc |
Methods and compositions for inhibition of bromodomain-containing proteins
|
|
US9227985B2
(en)
|
2013-03-15 |
2016-01-05 |
Incyte Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
WO2014173241A1
(en)
|
2013-04-26 |
2014-10-30 |
Beigene, Ltd. |
Substituted5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones
|
|
EP3019502B1
(en)
|
2013-07-08 |
2017-05-17 |
Incyte Holdings Corporation |
Tricyclic heterocycles as bet protein inhibitors
|
|
WO2015013635A2
(en)
|
2013-07-25 |
2015-01-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
EP3066101B1
(en)
|
2013-11-08 |
2020-07-29 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
US9309246B2
(en)
|
2013-12-19 |
2016-04-12 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
EP3099677A4
(en)
|
2014-01-31 |
2017-07-26 |
Dana-Farber Cancer Institute, Inc. |
Diaminopyrimidine benzenesulfone derivatives and uses thereof
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
JP2017504650A
(ja)
|
2014-01-31 |
2017-02-09 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
ジアゼパン誘導体およびその使用
|
|
KR20160130778A
(ko)
*
|
2014-02-28 |
2016-11-14 |
텐샤 세러퓨틱스 인코포레이티드 |
고인슐린혈증과 관련된 질환의 치료
|
|
JP2017511801A
(ja)
|
2014-02-28 |
2017-04-27 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
ＢＥＴブロモドメイン阻害剤としての９Ｈ−ピリミド［４，５−ｂ］インドールおよび関連類似体
|
|
CN106132968B
(zh)
*
|
2014-04-09 |
2019-04-05 |
康佳诺医疗科技发展有限公司 |
一种用于防止或治疗癌症的抑制溴结构域的化合物及含有该化合物的药物组合物
|
|
MY180775A
(en)
|
2014-04-23 |
2020-12-09 |
Incyte Corp |
1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
|
|
PL3157928T3
(pl)
|
2014-06-20 |
2019-07-31 |
Constellation Pharmaceuticals, Inc. |
Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu
|
|
EP3177626A4
(en)
|
2014-08-08 |
2017-12-27 |
Dana Farber Cancer Institute, Inc. |
Diazepane derivatives and uses thereof
|
|
MX2017001757A
(es)
|
2014-08-08 |
2017-05-30 |
Dana Farber Cancer Inst Inc |
Derivados de dihidropteridinona y sus usos.
|
|
US9527864B2
(en)
|
2014-09-15 |
2016-12-27 |
Incyte Corporation |
Tricyclic heterocycles as BET protein inhibitors
|
|
US10307407B2
(en)
|
2015-02-27 |
2019-06-04 |
The Regents Of The University Of Michigan |
9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors
|
|
GB201504694D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Covalent conjugates
|
|
WO2016196065A1
(en)
|
2015-05-29 |
2016-12-08 |
Genentech, Inc. |
Methods and compositions for assessing responsiveness of cancers to bet inhibitors
|
|
EP3307728A4
(en)
|
2015-06-12 |
2019-07-17 |
Dana Farber Cancer Institute, Inc. |
COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
|
|
WO2016203335A1
(en)
|
2015-06-18 |
2016-12-22 |
Pfizer Inc. |
Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
|
|
BR112017028178A2
(en)
|
2015-06-26 |
2018-08-28 |
Tensha Therapeutics, Inc. |
nut midline carcinoma treatment
|
|
KR20180035905A
(ko)
|
2015-08-10 |
2018-04-06 |
다나-파버 캔서 인스티튜트 인크. |
Bet 브로모도메인 억제제에 대한 저항성의 메카니즘
|
|
WO2017037567A1
(en)
*
|
2015-09-03 |
2017-03-09 |
Pfizer Inc. |
Regulators of frataxin
|
|
PE20181287A1
(es)
|
2015-09-11 |
2018-08-07 |
Dana Farber Cancer Inst Inc |
Ciano tienotriazolpirazinas y usos de las mismas
|
|
UA123946C2
(uk)
|
2015-09-11 |
2021-06-30 |
Дана-Фарбер Кенсер Інстітьют, Інк. |
Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
|
|
WO2017075377A1
(en)
|
2015-10-29 |
2017-05-04 |
Incyte Corporation |
Amorphous solid form of a bet protein inhibitor
|
|
CA3003288A1
(en)
|
2015-11-25 |
2017-06-01 |
Dana-Farber Cancer Institute, Inc. |
Bivalent bromodomain inhibitors and uses thereof
|
|
AU2016363632A1
(en)
|
2015-12-03 |
2018-06-07 |
Bayer Cropscience Aktiengesellschaft |
Mesoionic halogenated 3-(acetyl)-1-((1,3-thiazol-5-yl)methyl)-1h-imidazo(1,2-a)pyridin-4-ium-2-olate derivatives and related compounds as insecticides
|
|
JP6967522B2
(ja)
|
2016-02-15 |
2021-11-17 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｂｅｔブロモドメイン阻害剤としての融合１，４−オキサゼピンおよび関連類似体
|
|
JP7037500B2
(ja)
|
2016-04-06 |
2022-03-16 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
Ｍｄｍ２タンパク質分解剤
|
|
AU2017246453A1
(en)
|
2016-04-06 |
2018-11-08 |
The Regents Of The University Of Michigan |
Monofunctional intermediates for ligand-dependent target protein degradation
|
|
AU2017250076B2
(en)
|
2016-04-12 |
2021-07-22 |
The Regents Of The University Of Michigan |
Bet protein degraders
|
|
ES2793239T3
(es)
|
2016-04-15 |
2020-11-13 |
Abbvie Inc |
Inhibidores del bromodominio
|
|
KR102643344B1
(ko)
|
2016-06-20 |
2024-03-07 |
인사이트 코포레이션 |
Bet 저해제의 결정질 고체 형태
|
|
WO2018022802A1
(en)
|
2016-07-26 |
2018-02-01 |
University Of Southern California |
Selective bromodomain inhibition of fungal bdf1
|
|
CN110062759B
(zh)
|
2016-09-13 |
2022-05-24 |
密执安大学评议会 |
作为bet蛋白降解剂的稠合的1,4-氧氮杂䓬
|
|
ES2857743T3
(es)
|
2016-09-13 |
2021-09-29 |
Univ Michigan Regents |
1,4-diazepinas fusionadas como degradadores de proteína BET
|
|
US11046709B2
(en)
|
2017-02-03 |
2021-06-29 |
The Regents Of The University Of Michigan |
Fused 1,4-diazepines as BET bromodomain inhibitors
|
|
CN108727380A
(zh)
*
|
2017-04-13 |
2018-11-02 |
中国科学院上海药物研究所 |
一种brd4抑制剂及其制备和应用
|
|
BR112019025331A2
(pt)
|
2017-06-16 |
2020-06-23 |
Basf Se |
Compostos da fórmula (i), composição, métodos de proteção de safras e de combate, método não terapêutico de tratamento, semente, uso dos compostos e uso de composto
|
|
US11267822B2
(en)
|
2017-09-13 |
2022-03-08 |
The Regents Of The University Of Michigan |
BET bromodomain protein degraders with cleavable linkers
|
|
JP7402857B2
(ja)
|
2018-04-04 |
2023-12-21 |
エピオダイン，インク． |
オピオイド受容体モジュレーター、およびそれに関連する生成物ならびに方法
|
|
WO2021175432A1
(en)
|
2020-03-04 |
2021-09-10 |
Boehringer Ingelheim International Gmbh |
Method for administration of an anti cancer agent
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
AR122707A1
(es)
|
2020-06-23 |
2022-09-28 |
Genentech Inc |
Compuestos macrocíclicos y métodos de uso de los mismos
|
|
TW202304869A
(zh)
|
2021-04-05 |
2023-02-01 |
美商艾碧奧戴股份有限公司 |
類鴉片受體調節劑
|
|
WO2023041744A1
(en)
|
2021-09-17 |
2023-03-23 |
Institut Curie |
Bet inhibitors for treating pab1 deficient cancer
|
|
JP2025514712A
(ja)
|
2022-04-19 |
2025-05-09 |
ヌエヴォリューション・アクティーゼルスカブ |
ブロモドメインに対して活性な化合物
|